HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Huijing Ren Selected Research

SU 1498

11/2020Catalpol protects vascular structure and promotes angiogenesis in cerebral ischemic rats by targeting HIF-1α/VEGF.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Huijing Ren Research Topics

Disease

1Ischemic Stroke
01/2021
1Brain Ischemia (Cerebral Ischemia)
01/2021
1Wounds and Injuries (Trauma)
01/2021
1Infarction (Infarctions)
11/2020
1Ischemia
11/2020
1Hypoxia (Hypoxemia)
11/2020
1Stroke (Strokes)
11/2020

Drug/Important Bio-Agent (IBA)

2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 11/2020
2Glucose (Dextrose)FDA LinkGeneric
01/2021 - 11/2020
2Oxygen (Dioxygen)IBA
01/2021 - 11/2020
1EdaravoneIBA
01/2021
1catalpolIBA
11/2020
1SU 1498IBA
11/2020